Dalbavancin in the Treatment of Bacteremia and Endocarditis in People with Barriers to Standard Care
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Dalbavancin in the Treatment of Bacteremia and Endocarditis in People with Barriers to Standard Care
Authors
Keywords
-
Journal
Antibiotics-Basel
Volume 9, Issue 10, Pages 700
Publisher
MDPI AG
Online
2020-10-15
DOI
10.3390/antibiotics9100700
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Budget Impact Analysis of Dalbavancin in the Treatment of Acute Bacterial Skin and Skin Structure Infections in Three European Countries
- (2020) Andrea Marcellusi et al. CLINICAL DRUG INVESTIGATION
- Dalbavancin versus standard of care for the treatment of osteomyelitis in adults: A retrospective matched cohort study
- (2020) Thamer A. Almangour et al. SAUDI PHARMACEUTICAL JOURNAL
- Evaluation of partial oral antibiotic treatment for persons who inject drugs and are hospitalized with invasive infections
- (2020) Laura R Marks et al. CLINICAL INFECTIOUS DISEASES
- Use of a Standardized Dalbavancin Approach to Facilitate Earlier Hospital Discharge for Vulnerable Patients Receiving Prolonged Inpatient Antibiotic Therapy
- (2020) Axel A Vazquez Deida et al. Open Forum Infectious Diseases
- Risk of New Bloodstream Infections and Mortality Among People Who Inject Drugs With Infective Endocarditis
- (2020) Charlie Tan et al. JAMA Network Open
- Dalbavancin as Secondary Therapy for Serious Staphylococcus aureus Infections in a Vulnerable Patient Population
- (2019) Chloe Bryson-Cahn et al. Open Forum Infectious Diseases
- Antimicrobial activity of dalbavancin tested against Gram-positive organisms isolated from patients with infective endocarditis in US and European medical centres
- (2019) Helio S Sader et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Multicenter clinical experience of real life Dalbavancin use in gram-positive infections
- (2019) S. Wunsch et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- On- and off-label utilization of dalbavancin and oritavancin for Gram-positive infections
- (2019) Taylor Morrisette et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Long-Acting Lipoglycopeptides: “Lineless Antibiotics” for Serious Infections in Persons Who Use Drugs
- (2019) Taylor Morrisette et al. Open Forum Infectious Diseases
- A Wake-Up Call: Outcomes Following Infective Endocarditis in Persons Who Inject Drugs
- (2019) Asher J Schranz CLINICAL INFECTIOUS DISEASES
- Dalbavancin use in an academic medical centre and associated cost savings
- (2019) Amber C. Streifel et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Dalbavancin as a second-line treatment in methicillin-resistant Staphylococcus aureus prosthetic vascular graft infection
- (2019) Arturo Ciccullo et al. INFECTION
- Successful treatment of methicillin-sensitive Staphylococcus aureus tricuspid-valve endocarditis with dalbavancin as an outpatient in a person who injects drugs: A case report
- (2019) Aaron Hakim et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Pharmacist-led transitions-of-care services in primary care settings: Opportunities, experiences, and challenges
- (2019) Erin Slazak et al. JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION
- Dalbavancin as Primary and Sequential Treatment for Gram-Positive Infective Endocarditis: 2-Year Experience at the General Hospital of Vienna
- (2018) Selma Tobudic et al. CLINICAL INFECTIOUS DISEASES
- Emergence of dalbavancin non-susceptible, vancomycin-intermediate Staphylococcus aureus (VISA) after treatment of MRSA central line-associated bloodstream infection with a dalbavancin- and vancomycin-containing regimen
- (2018) B.J. Werth et al. CLINICAL MICROBIOLOGY AND INFECTION
- Partial Oral versus Intravenous Antibiotic Treatment of Endocarditis
- (2018) Kasper Iversen et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dalbavancin for the Treatment of Osteomyelitis in Adult Patients: A Randomized Clinical Trial of Efficacy and Safety
- (2018) Urania Rappo et al. Open Forum Infectious Diseases
- Unsuccessful treatment of methicillin-resistant Staphylococcus aureus endocarditis with dalbavancin
- (2017) J. M. Steele et al. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
- Relationship between Adherence to Oral Antibiotics and Postdischarge Clinical Outcomes among Patients Hospitalized with Staphylococcus aureus Skin Infections
- (2016) Samantha J. Eells et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Safety of Dalbavancin in the Treatment of Skin and Skin Structure Infections: A Pooled Analysis of Randomized, Comparative Studies
- (2015) Michael W. Dunne et al. DRUG SAFETY
- Once-Weekly Dalbavancin versus Daily Conventional Therapy for Skin Infection
- (2014) Helen W. Boucher et al. NEW ENGLAND JOURNAL OF MEDICINE
- Impact of reducing dosing frequency on adherence to oral therapies: a literature review and meta-analysis
- (2013) Alesia Sadosky et al. Patient Preference and Adherence
- Safe and successful treatment of intravenous drug users with a peripherally inserted central catheter in an outpatient parenteral antibiotic treatment service
- (2010) J. Ho et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Dalbavancin and telavancin: novel lipoglycopeptides for the treatment of Gram-positive infections
- (2008) George G Zhanel et al. Expert Review of Anti-Infective Therapy
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now